Latest Breaking News On - நீரஜ் அகர்வால் - Page 2 : comparemela.com
SWOG researchers to present practice-changing research at virtual ASCO 2021 SWOG always brings an impressive portfolio of work to the ASCO annual meeting, said SWOG Chair Charles D. Blanke, MD, and this year I m particularly excited about the research our investigators are presenting because it includes results that are likely to be practice-changing.
Investigators will present 12 abstracts from SWOG-led or co-led studies and 11 abstracts from studies led by other groups within the National Clinical Trials Network (NCTN).
Results from S1216 will be presented orally by study chair Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah. S1216 compared androgen deprivation therapy (ADT) combined with TAK-700 to the standard treatment of ADT with bicalutamide in patients who had metastatic hormone-sensitive prostate cancer. The study found that adding TAK-700 to ADT lengthened median progression-free survival in these patients and improved prostate-specific
California
United-states
United-kingdom
University-of-california-davis
British
Roche-genentech
Peter-black
Davendra-sohal
Jonathanw-riess
Eli-lilly
Charlesd-blanke
Emily-henderson
Dubai: An Indian expatriate in the UAE has shared the painful story of losing five of his relatives, including his own brother, within a span of 40 days recently.
Pankaj Agarwal, 50, an engineering consultant in Dubai, lost his brother, uncle, aunt and their two sons to COVID-19 in the north Indian state of Uttar Pradesh.
When his mobile rang on April 15 morning, Pankaj did not realise that it would bring the shocking news of the beginning of a series of deaths in his family.
“I was preparing to go to work at a construction site when I got a call from my mother who lives in India. She informed me that my maternal aunt (mother’s sister-in-law), Amita Agarwal, was no more. She was 61 and it was a sudden death after contracting COVID-19 in Prayagraj.”
Lucknow
Uttar-pradesh
India
Rudrapur
West-bengal
Dubai
Dubayy
United-arab-emirates
Delhi
Allahabad
Neeraj-agrawal
Vishal-agarwal
Lilly Announces Details of Presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
News provided by
Share this article
Share this article
INDIANAPOLIS, May 19, 2021 /PRNewswire/ New data from across Eli Lilly and Company s (NYSE: LLY) oncology portfolio will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 4-8, 2021. The data include new analyses of Verzenio
® (abemaciclib) from the Phase 3 monarchE trial in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer (EBC) with a high risk of recurrence who received neoadjuvant chemotherapy. In addition, the first clinical data from the Phase 1 study of Lilly s oral selective estrogen receptor degrader (SERD) will be presented at the meeting.
United-states
China
Chinese
American
Fabrice-andre
Fulvestrant-faslodex
Shao-zhimin
Torres-raquel
Eli-lilly
Deboras-bruno
Douglas-yee
Kevin-hern
vimarsana © 2020. All Rights Reserved.